Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Profound Medical Corp.

Profound Medical Corp. (PROF) Stock Overview

Explore Profound Medical Corp.’s financial performance, market position, analyst ratings, and future outlook.

PROF●NASDAQ
HealthcareMedical - Devices
$6.67
$0.26(3.75%)
U.S. Market opens in 3h 9m

Profound Medical Corp. (PROF)

Meyka AI Score

Z

Key Financials

Market Cap242.4M
P/E Ratio-6.93
EPS (TTM)$-1.24
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$6.27
3 Months$7.77
1 Year Target$5.78

PROF Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Profound Medical Corp. (NASDAQ: PROF) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Profound Medical Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PROF on the NASDAQ shows an RSI of 38.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.78 for the NASDAQ listing.

Key metrics behind Profound Medical Corp.'s NASDAQ-traded stock include a P/E ratio of -6.93 and a market capitalization of 242.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PROF on the NASDAQ.

Price Performance (NASDAQ: PROF)

1-Day Change
-3.75%
5-Day Change
-7.10%
1-Month Change
-6.71%
3-Month Change
-6.06%
6-Month Change
1.06%
Year-to-Date (YTD) Change
-15.25%
1-Year Change
22.39%
3-Year Change
-30.81%
5-Year Change
-56.26%
All-Time (Max) Change
-31.31%

Contact Information

https://www.profoundmedical.com
16474761350
2400 Skymark Avenue, Mississauga, ON, L4W 5K5

Company Facts

1,620 Employees
IPO DateOct 29, 2019
CountryCA
Actively Trading

Frequently Asked Questions